Cancer Cells and Their Immune Evasion Mechanisms
Author Information
Author(s): Weiss-Steider Benny, Soto-Cruz Isabel, Martinez-Campos Christian A, Mendoza-Rincon Jorge Flavio
Primary Institution: Laboratorio de Oncología Molecular. Unidad de Diferenciación Celular y Cáncer. FES-Zaragoza, Universidad Nacional Autónoma de México.
Hypothesis
Can cancer cells express the NKG2D receptor and proliferate in response to their own secreted stress molecules MICA and MICB?
Conclusion
Tumor cells can secrete MIC molecules and express their receptor, which may help them evade immune recognition.
Supporting Evidence
- THP-1 and U-937 cells produce and secrete MICA and MICB.
- These cells also express the receptor NKG2D.
- MICA and MICB induce dose-dependent proliferation in THP-1 and U-937 cells.
- Cervical cancer cell lines CALO and INBL also express MICA, MICB, and NKG2D.
Takeaway
Cancer cells can make special signals that help them grow and also have the ability to recognize those signals, which might help them hide from the immune system.
Methodology
Cell lines were evaluated using Western Blot, ELISA, flow cytometry, and immunocytochemistry to assess the expression and secretion of MICA, MICB, and NKG2D.
Potential Biases
Potential bias in cell line selection and experimental conditions.
Limitations
The study does not explore the long-term effects of MICA and MICB on tumor growth or immune response.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website